Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Media

Press Releases - 2000

Biosearch Italia and Newron Pharmaceuticals to collaborate

12/10/2000
English ENG   

Newron Pharmaceuticals S.p.A. announces data of phase I clinical trials of Its anti-epileptic and anti-parkinson compound NW-1015

14/03/2000
English ENG